SIRT6 and metabolic dysfunction-associated steatohepatitis: Indeed, Sirt6 activation through either genetic overexpression or pharmacological activation is known to be effective against rheumatoid arthritis 41, allergic airway inflammation 37, non-alcoholic steatohepatitis 42, adipose tissue inflammation 43, and anaphylaxis 12.